Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin

被引：98
作者：
Yang, Jie [1 ]
Li, Minmin [2 ]
Shen, Xintian [1 ]
Liu, Shuwen [1 ]
机构：
[1] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China
[2] Jinan Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou 510630, Guangdong, Peoples R China
来源：
VIRUSES-BASEL | 2013年 / 5卷 / 01期
关键词：
influenza A virus; hemagglutinin; viral entry; antiviral drugs; MEDIATED MEMBRANE-FUSION; CONFORMATIONAL-CHANGE; POTENT INHIBITORS; VIRAL ATTACHMENT; RECEPTOR-BINDING; CLEAVAGE SITE; IN-VIVO; H5N1; IDENTIFICATION; GLYCOSYLATION;
D O I：
10.3390/v5010352
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Influenza A virus (IAV) has caused seasonal influenza epidemics and influenza pandemics, which resulted in serious threat to public health and socioeconomic impacts. Until now, only 5 drugs belong to two categories are used for prophylaxis and treatment of IAV infection. Hemagglutinin (HA), the envelope glycoprotein of IAV, plays a critical role in viral binding, fusion and entry. Therefore, HA is an attractive target for developing anti-IAV drugs to block the entry step of IAV infection. Here we reviewed the recent progress in the study of conformational changes of HA during viral fusion process and the development of HA-based IAV entry inhibitors, which may provide a new choice for controlling future influenza pandemics.
引用
收藏
页码：352 / 373
页数：22
相关论文
共 88 条
  • [1] An avian influenza H5N1 virus that binds to a human-type receptor
    Auewarakul, Prasert
    Suptawiwat, Ornpreya
    Kongchanagul, Alita
    Sangma, Chak
    Suzuki, Yasuo
    Ungchusak, Kumnuan
    Louisirirotchanakul, Suda
    Lerdsamran, Hatairat
    Pooruk, Phisanu
    Thitithanyanont, Arunee
    Pittayawonganon, Chakrarat
    Guo, Chao-Tan
    HiramatSU, Hiroaki
    Jampangern, Wipawee
    Chunsutthiwat, Supamit
    Puthavathanal, Pilaipan
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (18) : 9950 - 9955
  • [2] Beppu Y, 1997, J BIOCHEM-TOKYO, V121, P309
  • [3] INHIBITION OF THE FUSION-INDUCING CONFORMATIONAL CHANGE OF INFLUENZA HEMAGGLUTININ BY BENZOQUINONES AND HYDROQUINONES
    BODIAN, DL
    YAMASAKI, RB
    BUSWELL, RL
    STEARNS, JF
    WHITE, JM
    KUNTZ, ID
    [J]. BIOCHEMISTRY, 1993, 32 (12) : 2967 - 2978
  • [4] Arbidol:: A broad-spectrum antiviral compound that blocks viral fusion
    Boriskin, Y. S.
    Leneva, I. A.
    Pecheur, E. -I.
    Polyak, S. J.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (10) : 997 - 1005
  • [5] Curcumin inhibits influenza virus infection and haemagglutination activity
    Chen, Da-Yuan
    Shien, Jui-Hung
    Tiley, Laurence
    Chiou, Shyan-Song
    Wang, Sheng-Yang
    Chang, Tien-Jye
    Lee, Ya-Jane
    Chan, Kun-Wei
    Hsu, Wei-Li
    [J]. FOOD CHEMISTRY, 2010, 119 (04) : 1346 - 1351
  • [6] Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation
    Chen, J
    Lee, KH
    Steinhauer, DA
    Stevens, DJ
    Skehel, JJ
    Wiley, DC
    [J]. CELL, 1998, 95 (03) : 409 - 417
  • [7] Activity of Andrographolide and Its Derivatives against Influenza Virus in Vivo and in Vitro
    Chen, Jian-Xin
    Xue, Hui-Jun
    Ye, Wen-Cai
    Fang, Bing-Hu
    Liu, Ya-Hong
    Yuan, Shao-Hua
    Yu, Pei
    Wang, Yu-Qiang
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (08) : 1385 - 1391
  • [8] Antivirals Targeting Influenza A Virus
    Das, Kalyan
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (14) : 6263 - 6277
  • [9] Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
    de Jong, MD
    Thanh, TT
    Khanh, TH
    Hien, VM
    Smith, GJD
    Chau, NV
    Cam, BV
    Qui, PT
    Ha, DQ
    Guan, Y
    Peiris, JSM
    Hien, TT
    Farrar, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) : 2667 - 2672
  • [10] Structure-activity relationships of saponin derivatives: A series of entry inhibitors for highly pathogenic H5N1 influenza virus
    Ding, Ning
    Chen, Qing
    Zhang, Wei
    Ren, Sumei
    Guo, Ying
    Li, Yingxia
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 53 : 316 - 326
123456789